Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia
Status:
Completed
Trial end date:
2015-10-12
Target enrollment:
Participant gender:
Summary
This study is a multi-center, randomized, active-controlled, double-blind, non-inferiority,
phase III clinical trial evaluating efficacy and safety of once-daily mosapride
(UI05MSP015CT) in patients with functional dyspepsia.